THRESHOLD PHARMACEUTICALS, INC. Chart calendar Threshold Pharmaceuticals, Inc.
61ffc5769640077a659dda69b.GGCI-W698koMIz4ORMpJ9RiXu84DYvBbRR9TO7ZTyOA.cCvvkiLevHNqUmQ2FI5_wWil7IlEL7YiEkkASuE18bJ2UP6TG8qAM2puSQ~70ecc99de1227d52615abdc74377ea17
Upcoming events on Threshold Pharmaceuticals, Inc.
Past events on Threshold Pharmaceuticals, Inc.
| 09/04/2024 06:30 pm | American Association for Cancer Research Meeting - Abstract No:CT191 |
| 29/03/2024 05:51 pm | Q4 2023 Earnings Release |
| 14/02/2024 07:50 pm | Oppenheimer Healthcare Life Sciences Conference |
| 28/11/2023 | Evercore ISI HealthCONx Conference |
| 15/11/2023 09:25 pm | Stifel Healthcare Conference |
| 14/11/2023 02:41 am | Q3 2023 Earnings Release |
| 08/11/2023 | UBS BioPharma Conference |
| 27/10/2023 07:30 pm | Annual General Meeting |
| 12/09/2023 09:30 am | H.C. Wainwright Global Investment Conference |
| 14/08/2023 | Reverse Split: 1 of 15 |
| 11/08/2023 06:30 pm | Extraordinary Shareholders Meeting |
| 10/08/2023 05:38 pm | Q2 2023 Earnings Release |
| 07/06/2023 | Jefferies Global Healthcare Conference |
| 05/06/2023 | BIO International Convention |
| 03/06/2023 06:30 pm | American Society of Clinical Oncology Conference - Poster Number: 2552 |
| 16/05/2023 01:43 am | Q1 2023 Earnings Release |
| 17/04/2023 11:00 pm | American Association for Cancer Research Meeting |
| 31/03/2023 03:40 am | Q4 2022 Earnings Release |
| 15/03/2023 10:10 pm | Oppenheimer Healthcare Conference - Fireside Chat |
| 14/03/2023 | Barclays Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22,3 20,7 7.78% | 18,8 22,9 -17.62% | 38,7 34,7 11.62% | 19,8 25,9 -23.86% | 57,3 58,1 -1.31% | 12,7 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -96,9 -87,4 -10.91% | -73,4 -87,9 16.49% | -81,5 -75,1 -8.46% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -48,3 -62,8 23.1% | -101 -95,5 -5.65% | -80,1 -89,1 10.1% | -88,9 -88,5 -0.41% | -10,5 -9,39 -11.52% | -23,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -69,4 -69,1 -0.4% | -105 -94,9 -10.5% | -83,0 -84,2 1.42% | -92,7 -91,0 -1.8% | -8,14 -11,6 30.13% | -22,4 |
|
Net income Million USD | Released Forecast Spread | -69,4 -62,1 -11.8% | -105 -97,5 -7.63% | -83,0 -91,5 9.25% | -92,7 -91,0 -1.85% | -8,12 -11,6 30.22% | -22,4 |
|
EPS USD | Released Forecast Spread | -27,9 -24,8 -12.39% | -33,0 -30,3 -8.9% | -22,5 -25,1 10.32% | -24,7 -19,5 -26.92% | -1,80 -2,62 31.3% | -3,25 |
| Announcement Date | 12/03/20 | 18/03/21 | 28/03/22 | 30/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 18,0 15,0 19.51% | 8,49 5,36 58.34% | 4,42 5,85 -24.45% | 4,24 3,08 37.66% | 2,61 8,81 -70.37% | 36,6 2,25 1527.96% | 6,87 2,58 166.6% | 6,80 2,47 175.7% | 7,02 7,78 -9.76% | 5,90 | 6,13 | 0,33 | 0,35 |
|
EBITDA Million USD | Released Forecast Spread | -7,50 -24,1 68.88% | -21,6 -23,1 6.33% | |||||||||||
|
EBIT Million USD | Released Forecast Spread | -9,30 -18,3 49.09% | -20,6 -23,2 11.04% | -23,8 -23,1 -3.27% | -23,7 -26,7 11.35% | -21,1 -20,4 -3.31% | 11,8 -15,4 176.73% | -11,7 -19,2 38.91% | -5,14 -11,3 54.5% | -5,37 -4,29 -25.2% | -4,48 | -3,55 | -7,94 | -7,71 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,2 -11,8 12.92% | -21,6 -21,3 -1.33% | -24,7 -24,7 -0.1% | -24,6 -27,3 9.75% | -22,0 -22,9 3.84% | 10,8 -15,7 168.92% | -10,9 -19,5 44.4% | -4,15 -11,6 64.27% | -3,96 -5,01 21.01% | -4,25 | -3,17 | -7,55 | -7,45 |
|
Net income Million USD | Released Forecast Spread | -10,2 -18,7 45.15% | -21,6 -24,0 10.11% | -24,7 -24,3 -2.02% | -24,6 -27,2 9.42% | -22,0 -20,8 -6.14% | 10,8 -15,7 168.92% | -10,9 -19,5 44.4% | -4,15 -11,6 64.27% | -3,95 -5,01 21.23% | -4,25 | -3,17 | -7,55 | -7,45 |
|
EPS USD | Released Forecast Spread | -2,70 -5,15 47.59% | -5,70 -6,30 9.52% | -6,60 -6,45 -2.33% | -6,60 -7,23 8.71% | -5,85 -4,58 -27.87% | 2,85 -4,20 167.86% | -0,19 -5,18 96.33% | -0,82 -1,95 57.95% | -0,73 -0,97 24.74% | -0,78 | -0,47 | -1,11 | -0,89 |
| Announcement Date | 28/03/22 | 13/05/22 | 11/08/22 | 10/11/22 | 30/03/23 | 15/05/23 | 10/08/23 | 13/11/23 | 29/03/24 | - | - | - | - |
More events
Past sector events for Threshold Pharmaceuticals, Inc.
| 03/05/2024 04:30 pm | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
